Polymyxin B
- Product NDC
- 70860-103
- 11-digit product format
- 708600103
- Labeler code
- 70860
- Product ID
- 70860-103_363231fb-74f3-40e3-a278-92ccb5dad1cf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- polymyxin B sulfate
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS; OPHTHALMIC
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA207322
- Marketing category
- ANDA
- Marketing start
- 2017-01-01
- Marketing end
- 0000-00-00
- Substance
- POLYMYXIN B SULFATE
- Active strength
- 500000 [iU]/1
- Pharmacologic classes
- Polymyxin-class Antibacterial [EPC],Polymyxins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-103-10 | 70860010310 | 10 VIAL in 1 CARTON (70860-103-10) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (70860-103-41) | 10 vial | 2017-01-01 | 0000-00-00 | No | No | Current |